Preventing and Managing Toxicities of High-Dose Methotrexate

High-dose methotrexate (HDMTX), defined as a dose higher than 500 mg/m(2), is used to treat a range of adult and childhood cancers. Although HDMTX is safely administered to most patients, it can cause significant toxicity, including acute kidney injury (AKI) in 2%–12% of patients. Nephrotoxicity res...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Scott C., McCormick, John, Pui, Ching-Hon, Buddington, Randall K., Harvey, R. Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
New Drug Development and Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153332/
https://www.ncbi.nlm.nih.gov/pubmed/27496039
http://dx.doi.org/10.1634/theoncologist.2015-0164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153332/
https://www.ncbi.nlm.nih.gov/pubmed/27496039
http://dx.doi.org/10.1634/theoncologist.2015-0164

Ejemplares similares